SEARCHCOHORTcardiology, pulmonology

cohort·cardiology, pulmonology, internal medicine, observational study·PMC10058864

Patient Satisfaction with a Dedicated Infusion Pump for Subcutaneous Treprostinil to Treat Pulmonary Arterial Hypertension

Journal of Personalized Medicine · 5 authors, 3 centres

AI SUMMARY

FIDELITY 100%

This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.

AGENT 01 · STRUCTURED SUMMARY

TRACE TO SOURCE

“

TL;DR

This observational study assessed 13 pulmonary arterial hypertension patients' satisfaction with a new portable I-Jet infusion pump for self-administering subcutaneous treprostinil over two months.

Full summary

922 CHARS

This was a single-center, observational, prospective study of 13 pulmonary arterial hypertension patients switched to the new portable I-Jet infusion pump for self-administration of subcutaneous treprostinil. After two months, patients completed questionnaires assessing satisfaction, compliance, and training needs. The primary finding was high patient satisfaction: 76.9% found the pump easy and convenient, 100% reported feeling fully compliant and confident, and 76.9% would choose the pump again. All patients reported the administration was safe, with no reported device malfunctions or adverse events. A trainer nurse also confirmed patient satisfaction and the simplicity of use. The study's limitations include a small sample size, single-center design, short follow-up, and the use of a non-validated questionnaire without a comparator group, which limits internal validity but may reflect real-world experience.

STUDY TYPE

cohort

SPECIALTY

cardiology

SUMMARISED BY

AI pipeline

FIDELITY CHECK

100% · A

ORIGINAL PAPER

PMC10058864

Patient Satisfaction with a Dedicated Infusion Pump for Subcutaneous Treprostinil to Treat Pulmonary Arterial Hypertension

Journal of Personalized Medicine

READ THE FULL PAPER

ABSTRACT

Background and Objectives : Parenteral prostacyclins are crucial in the pharmacological treatment of pulmonary arterial hypertension (PAH). Indeed, subcutaneous administration of treprostinil has been associated with considerable clinical and hemodynamic improvement, right-sided heart reverse remodeling, and long-term survival benefit. However, evidence on patient perceptions about handling a subcutaneous infusion pump for self-treatment administration and nurse views about training the patients are lacking. This study aimed to describe the perception of PAH patients and nurses regarding the use of the new portable I-Jet infusion pump for the self-administration of subcutaneous treprostinil, as well as its real-world training needs. Materials and Methods : The study is an open, observational, prospective, single-center, non-interventional study. Patients with PAH on stable therapy with subcutaneous treprostinil were invited to take part in the study at their start of use of the portable I-Jet infusion pump for the self-administration of treatment. Participants filled in a questionnaire to report their satisfaction with the use of the pump, as well as their compliance, confidence, convenience, preferences, technical issues, and perceptions of the training they received. Results : Thirteen patients completed the questionnaire after being on the pump for 2 months: 69% were females and the mean age was 51 years. The most frequent PAH etiologies were congenital heart disease (46.2%) and idiopathic PAH (38.4%). Most patients were either World Health Organization (WHO) functional class II (53.8%) or III (46.2%). Ten patients (76.9%) found the pump easy and convenient to live with. All patients declared themselves to be fully compliant and confident in using the pump ( n = 13) at the end of the study follow-up. Ten patients (76.9%) would choose the new pump in the future. None of the patients made reference to technical issues that required additional hospital visits. Eight patients (61.6%) reported that learning how to use the I-Jet infusion pump was easy or very easy, and none considered that further training was needed. One trainer nurse was interviewed and confirmed the satisfaction of patients and the simplicity of usage and training. Conclusions : PAH patients were highly satisfied with the use of the new portable I-Jet infusion pump for self-administering subcutaneous treprostinil. Convenience and ease of use were valuable and commonly reported features. Moreover, the training requirement was simple. These preliminary findings support the routine use of the I-Jet infusion pump.

CITATION EXPORT

Marcin Waligóra, Barbara Żuławinska, Michał Tomaszewski et al.. Patient Satisfaction with a Dedicated Infusion Pump for Subcutaneous Treprostinil to Treat Pulmonary Arterial Hypertension. Journal of Personalized Medicine. (2023). https://doi.org/10.3390/jpm13030423

AUTHORS

5 · 3 CENTRES

Marcin Waligóra, Barbara Żuławinska, Michał Tomaszewski, Pere Roset, Grzegorz Kopeć

1Pulmonary Circulation Centre, Department of Cardiac and Vascular Diseases, Faculty of Medicine, Jagiellonian University Medical College Centre for Rare Cardiovascular Diseases John Paul II Hospital in Krakow, 31-202 Krakow, Poland
2Department of Cardiology, Medical University of Lublin, 20-090 Lublin, Poland
3Ferrer International, 08029 Barcelona, Spain

EDITOR / REVIEWER

Hyun Lee, Marco U. Scalese